jepcastel > Drugs | BibSonomy

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

No matching posts.

⟨⟨
⟨
⟩
⟩⟩

publications (hide)7
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis
X. Jiao, P. Qiu, Z. Song, X. Peng, H. Li, L. Zeng, and L. Zhang. 80 (11): 1625--1657 (2024)
30 days ago by @jepcastel
show all tags
SystematicReview
drugs
guidelines
pregnancy
review
use
SystematicReviewdrugsguidelinespregnancyreviewuse
(0)
copydeleteadd this publication to your clipboard
1The statistics of phase 0 trials.
L. Rubinstein, S. Steinberg, S. Kummar, R. Kinders, R. Parchment, A. Murgo, J. Tomaszewski, and J. Doroshow. Statistics in medicine, 29 (10): 1072-6 (May 2010)6503<m:linebreak></m:linebreak>JID: 8215016; 0 (Antineoplastic Agents); 0 (Drugs, Investigational); ppublish;<m:linebreak></m:linebreak>Disseny; Fase 0.
2 years ago by @jepcastel
show all tags
AntineoplasticAgents
AntineoplasticAgents:administration&dosage
AntineoplasticAgents:pharmacokinetics
ClinicalTrialsasTopic
ClinicalTrialsasTopic:methods
DataInterpretation
Drugs
Humans
Investigational
Investigational:pharmacokinetics
Investigational:pharmacology
Neoplasms
Neoplasms:drugtherapy
Neoplasms:metabolism
Pharmacokinetics
Statistical
AntineoplasticAgentsAntineoplasticAgents:administration&dosageAntineoplasticAgents:pharmacokineticsClinicalTrialsasTopicClinicalTrialsasTopic:methodsDataInterpretationDrugsHumansInvestigationalInvestigational:pharmacokineticsInvestigational:pharmacologyNeoplasmsNeoplasms:drugtherapyNeoplasms:metabolismPharmacokineticsStatistical
(0)
copydeleteadd this publication to your clipboard
1Changing physician prescribing behavior: a low-cost administrative policy that reduced the use of brand name nonsteroidal anti-inflammatory drugs.
J. Ahluwalia, M. Weisenberger, A. Bernard, and S. McNagny. Preventive medicine, 25 (6): 668-72 (1996)2580.
2 years ago by @jepcastel
show all tags
Anti-InflammatoryAgents
Chi-SquareDistribution
CostSavings
CostSavings:methods
CostSavings:statistics&numericaldata
CostSavings:utilization
Drugs
Generic
Generic:economics
Hospitals
Humans
InterventionStudies
Non-Steroidal
Non-Steroidal:economics
OddsRatio
Physician'sPracticePatterns
Physician'sPracticePatterns:economics
Public
Public:economics
Public:methods
Anti-InflammatoryAgentsChi-SquareDistributionCostSavingsCostSavings:methodsCostSavings:statistics&numericaldataCostSavings:utilizationDrugsGenericGeneric:economicsHospitalsHumansInterventionStudiesNon-SteroidalNon-Steroidal:economicsOddsRatioPhysician'sPracticePatternsPhysician'sPracticePatterns:economicsPublicPublic:economicsPublic:methods
(0)
copydeleteadd this publication to your clipboard
1Comparative efficacy and effectiveness: an opportunity for clinical pharmacology.
R. Lalonde, and R. Willke. Clinical pharmacology and therapeutics, 90 (6): 761-3 (December 2011)6577<m:linebreak></m:linebreak>JID: 0372741; 0 (Drugs, Generic); ppublish;<m:linebreak></m:linebreak>CER.
2 years ago by @jepcastel
show all tags
Clinical
Clinical:methods
ComparativeEffectivenessResearch
ComparativeEffectivenessResearch:organization&
DrugApproval
DrugDesign
DrugIndustry
DrugIndustry:economics
DrugIndustry:organization&administration
Drugs
Generic
Generic:economics
HealthCareCosts
HealthServicesNeedsandDemand
Humans
Pharmacology
ReimbursementMechanisms
UnitedStates
ClinicalClinical:methodsComparativeEffectivenessResearchComparativeEffectivenessResearch:organization&DrugApprovalDrugDesignDrugIndustryDrugIndustry:economicsDrugIndustry:organization&administrationDrugsGenericGeneric:economicsHealthCareCostsHealthServicesNeedsandDemandHumansPharmacologyReimbursementMechanismsUnitedStates
(0)
copydeleteadd this publication to your clipboard
1Practical and legislative topics in relation to the manufacturing and importation of human medicinal products in non commercial clinical trials.
B. Gómez, M. Placeres, and N. Riba. Medicina clínica, 132 (8): 322-7 (March 2009)4931<m:linebreak></m:linebreak>JID: 0376377; 2008/08/04 received; 2008/10/17 accepted; 2009/02/15 aheadofprint; ppublish;<m:linebreak></m:linebreak>Polítiques de recerca.
2 years ago by @jepcastel
show all tags
Accreditation
ClinicalTrialsasTopic
ClinicalTrialsasTopic:legislation&jurisprude
DrugIndustry
DrugIndustry:legislation&jurisprudence
Drugs
Europe
Humans
Investigational
PharmaceuticalServices
Spain
AccreditationClinicalTrialsasTopicClinicalTrialsasTopic:legislation&jurisprudeDrugIndustryDrugIndustry:legislation&jurisprudenceDrugsEuropeHumansInvestigationalPharmaceuticalServicesSpain
(0)
copydeleteadd this publication to your clipboard
1Relationship between sample size and the definition of equivalence in non-inferiority drug studies.
J. Millar, and V. Burke. Journal of clinical pharmacy and therapeutics, 27 (5): 329-33 (October 2002)3454<m:linebreak></m:linebreak>Tests d'equivalència.
2 years ago by @jepcastel
show all tags
ClinicalTrialsasTopic
ClinicalTrialsasTopic:statistics&numericald
Drugs
Humans
Investigational
Investigational:pharmacokinetics
SampleSize
TherapeuticEquivalency
ClinicalTrialsasTopicClinicalTrialsasTopic:statistics&numericaldDrugsHumansInvestigationalInvestigational:pharmacokineticsSampleSizeTherapeuticEquivalency
(0)
copydeleteadd this publication to your clipboard
1Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development.
J. Quinlan, B. Gaydos, J. Maca, and M. Krams. Clinical trials (London, England), 7 (2): 167-73 (April 2010)5547<br/>JID: 101197451; 2010/03/25 aheadofprint; ppublish;<br/><br/>Disseny; Dissenys adaptatius.
2 years ago by @jepcastel
show all tags
ClinicalTrialsasTopic
ClinicalTrialsasTopic:methods
DrugIndustry
DrugIndustry:organization&administration
Drugs
Humans
Investigational
ResearchDesign
RiskAssessment
Societies
ClinicalTrialsasTopicClinicalTrialsasTopic:methodsDrugIndustryDrugIndustry:organization&administrationDrugsHumansInvestigationalResearchDesignRiskAssessmentSocieties
(0)
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
⟩
⟩⟩

BibSonomy

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)7
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis

1The statistics of phase 0 trials.

1Changing physician prescribing behavior: a low-cost administrative policy that reduced the use of brand name nonsteroidal anti-inflammatory drugs.

1Comparative efficacy and effectiveness: an opportunity for clinical pharmacology.

1Practical and legislative topics in relation to the manufacturing and importation of human medicinal products in non commercial clinical trials.

1Relationship between sample size and the definition of equivalence in non-inferiority drug studies.

1Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development.

browse

related tags

concepts

tags

bookmarks (hide) displayallbookmarks onlybookmarks per page5102050100 sort byadded attitle RSSBibTeXXML

publications (hide)7 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

browse

related tags

tags

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)7
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...